|
Volumn 3, Issue 1, 2000, Pages 48-62
|
Contraceptive update Y2K: Need for contraception and new contraceptive options
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHORIONIC GONADOTROPIN;
CONTRACEPTIVE AGENT;
COPPER INTRAUTERINE DEVICE;
DESOGESTREL PLUS ETHINYLESTRADIOL;
ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE;
ESTROGEN;
ETHINYLESTRADIOL PLUS ETONOGESTREL;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
ETHINYLESTRADIOL PLUS NORELGESTROMIN;
ETHINYLESTRADIOL PLUS NORGESTIMATE;
ETHINYLESTRADIOL PLUS NORGESTREL;
ETONOGESTREL;
GESTAGEN;
HEXYLRESORCINOL;
LEVONORGESTREL;
LEVORA;
LO OGESTREL;
MECLOZINE;
MEDROXYPROGESTERONE ACETATE;
MESTRANOL PLUS NORETYNODREL;
MIFEPRISTONE;
NORGESTREL;
NORPLANT SYSTEM;
ORAL CONTRACEPTIVE AGENT;
PROGESTERONE;
PROGESTERONE DERIVATIVE;
TRIVORA;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ARTICLE;
BACKACHE;
BIRTH CONTROL;
CANCER RISK;
CONDOM;
CONTRACEPTION;
CONTROLLED STUDY;
DRUG SAFETY;
DYSMENORRHEA;
FEMALE;
HORMONAL CONTRACEPTION;
HUMAN;
INTRAUTERINE CONTRACEPTIVE DEVICE;
MASTALGIA;
MENSTRUATION DISORDER;
NAUSEA AND VOMITING;
ORAL CONTRACEPTION;
RISK BENEFIT ANALYSIS;
THROMBOEMBOLISM;
THROMBOPHILIA;
UNITED STATES;
|
EID: 0034436646
PISSN: 10983597
EISSN: None
Source Type: Journal
DOI: 10.1016/S1098-3597(00)90021-8 Document Type: Article |
Times cited : (6)
|
References (27)
|